Addiction

Ibogaine by David Dardashti Introduces New Algorithm for Methadone Addiction

Algorithm Varies Slightly from Suboxone and Focuses on Continuously Dosed Ibogaine Treatment Methadone algorithm Ibogaine by David Dardashti is improving…

8 months ago

Ibogaine By David Dardashti Introduces New Algorithm for Depression Treatment

A Revolutionary Advancement in Depression Treatments Ibogaine by David Dardashti A new algorithm to help combat depression MIAMI, April 21,…

8 months ago

Mobilize Recovery Cross-Country Bus Tour Galvanizes Community, Prevents Overdoses

Fifteen cities to host events in partnership with iHeartMedia, Meta, SAMHSA, Inseparable, and dozens of community partners coinciding with nationwide…

8 months ago

Revolutionizing Pain Management in Urgent Care Centers

United Pain Urgent Care is Pioneering Non-Opioid Solutions for Acute Pain RENO, NV / ACCESSWIRE / April 17, 2023 /…

8 months ago

BrainsWay Expands Deep TMS™ Access in Israel Following Significant Increase in Reimbursement Rates

Company Announces 11th Recent System Installed in Israel, with More Expected this YearBURLINGTON, Mass. and JERUSALEM, April 17, 2024 (GLOBE…

8 months ago

Clearmind Medicine Announces Exclusive Licensing Agreement for Generation 3.0 Psychedelic Compounds for the Treatment of Mental Disorders

Tel Aviv, Israel / Vancouver, Canada, April 17, 2024 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: CWY0) (“Clearmind”…

8 months ago

atai Life Sciences Announces the Publication of Beckley Psytech’s Phase 1 Study of BPL-003 in the Journal of Psychopharmacology

BPL-003 is Beckley Psytech’s novel patent-protected benzoate salt formulation of 5-MeO-DMT that is administered intranasally.BPL-003 was shown to be safe…

8 months ago

Awakn Life Sciences Announces Closing of Tranche of Private Placement

Toronto, Ontario--(Newsfile Corp. - April 17, 2024) - Awakn Life Sciences Corp. (CSE: AWKN) (OTCQB: AWKNF) (FSE: 954) ("Awakn" or…

8 months ago

Chromocell Issues Letter to Stockholders from Chief Executive Officer

FREEHOLD, N.J., April 09, 2024 (GLOBE NEWSWIRE) -- Chromocell Therapeutics Corporation (“Chromocell”, or the “Company”), (NYSE American: CHRO), a pioneer…

9 months ago